缺血性二尖瓣反流持久二尖瓣修复后的临床结局
本研究纳入166例慢性缺血性二尖瓣反流且左室射血分数≤40%行限制性二尖瓣环成形术患者,排除20例术后复发反流者,最终分析146例反流控制良好者。随访65±34个月,52%患者死亡或心衰再入院,年龄和估算肾小球滤过率为独立预测因素,持久修复不一定带来良好临床结局。
要点
- 即使无复发性二尖瓣反流,约半数患者5年内死亡或心衰再入院
- 年龄和估算肾小球滤过率是长期死亡或心衰再入院的独立预测因素
- 不良事件可能与肾功能不全导致容量负荷过重及肺血流动力学不佳相关
核心结论
- 在无复发性二尖瓣反流的患者中,约50%在5年随访期间死亡或因心衰住院,表明持久二尖瓣修复并不总是带来良好临床结局。
- 不良事件可能与肾功能不全导致的容量负荷过重及较差的肺血流动力学相关。
研究设计与样本
- 回顾性队列研究,1999年至2015年纳入166例慢性缺血性二尖瓣反流且左室射血分数≤40%行限制性二尖瓣环成形术患者。
- 随访65±34个月,超声心动图评估809次(平均4.9±2.4次),排除20例术后复发中度或重度二尖瓣反流者,最终分析146例(年龄68[63-75]岁)反流控制良好患者。
主要发现
- 76例患者(52%)发生61例死亡或27例心衰再入院。
- 年龄(校正风险比1.05;P=.001)和估算肾小球滤过率(校正风险比0.61;P=.001)为长期死亡或心衰再入院的独立预测因素。
- 不良事件组与无不良事件组术后左室功能恢复程度相当,但不良事件组随访期间收缩期肺动脉压、三尖瓣反流严重程度、下腔静脉内径和血浆脑钠肽水平更高(组效应P<.05)。
临床怎么用
- 对缺血性二尖瓣反流患者行持久二尖瓣修复后,应关注肾功能和肺血流动力学,以识别心衰再入院高风险者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to clarify the incidence and determinants of postoperative adverse events in patients with ischemic cardiomyopathy who achieved long-term durable mitral valve repair. METHODS: Between 1999 and 2015, 166 patients with chronic ischemic mitral regurgitation (MR) and a left ventricular ejection fraction ≤40% underwent restrictive mitral annuloplasty. During follow-up (65 ± 34 months), echocardiographic assessments were performed 809 times (mean, 4.9 ± 2.4 times), and 20 patients who had postoperative recurrent MR (moderate or severe) were excluded. Finally, 146 patients (aged 68 [63-75] years) whose MR was well controlled over time were included. RESULTS: A total of 61 deaths or 27 readmissions for heart failure were observed in 76 patients (52%). Among hospital survivors, age (adjusted hazard ratio, 1.05; P = .001) and estimated glomerular filtration rate (adjusted hazard ratio, 0.61; P = .001) were identified as independent predictors of long-term mortality or readmission for heart failure. The degree of postoperative left ventricular function recovery was comparable between patients with and without adverse events. However, the former group showed greater values for systolic pulmonary artery pressure, tricuspid regurgitation severity, inferior vena cava dimension, and plasma brain natriuretic peptide level throughout the follow-up period (group effect P < .05 for all). CONCLUSIONS: Approximately 50% of patients died or were hospitalized for heart failure even in the absence of recurrent MR during the 5-year follow-up, a finding indicating that durable mitral repair does not always lead to favorable clinical outcomes. The adverse events may have been related to volume overload secondary to impaired renal function and less favorable pulmonary hemodynamics.
引用
- Senzai M, Kainuma S, Toda K, et al. Clinical Outcomes After Durable Mitral Valve Repair for Ischemic Mitral Regurgitation. Ann Thorac Surg. 2021. PMID: 34534528. doi:10.1016/j.athoracsur.2021.08.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。